Drug Trial Radar · NCT06489028
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III)
Last checked: Nov 20, 2026Latest source record: Oct 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
250
Planned (sponsor's estimate)
Start
Dec 26, 2024
Primary completion
Apr 2027
Study completion Sep 2027
Sponsor
- Lead sponsor
- RHEACELL GmbH & Co. KGIndustry
- Sponsor type
- Industry
- Collaborators
- FGK Clinical Research GmbH
- First posted
- Jul 5, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this clinical trial is to investigate the efficacy and safety of allo-APZ2-CVU, administered topically on therapy-resistant non-healing CVUs compared to placebo.
Conditions
- Venous Leg Ulcer
Interventions
allo-APZ2-CVUDrug
Allogeneic dermal ABCB5-positive Mesenchymal Stromal Cells (ABCB5+ MSCs)
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Complete wound closureTime frame: 18 weeks
Locations
15 sites in 12 countries. Site status is shown where the registry gives one.
RHEACELL Clinical Trial Site
Hialeah, Florida
RHEACELL Clinical Trial Site
Miami, Florida
RHEACELL Clinical Trial Site
Boston, Massachusetts
RHEACELL Clinical Trial Site
Minneapolis, Minnesota
RHEACELL Clinical Trial Site
Multiple Locations, Austria
RHEACELL Clinical Trial Site
Multiple Locations, Czechia
RHEACELL Clinical Trial Site
Multiple Locations, France
RHEACELL Clinical Trial Site
Several Locations, Germany
RHEACELL Clinical Trial Site
Multiple Locations, Hungary
RHEACELL Clinical Trial Site
Multiple Locations, Italy
RHEACELL Clinical Trial Site
Multiple Locations, Netherlands
RHEACELL Clinical Trial Site
Multiple Locations, Poland
RHEACELL Clinical Trial Site
Multiple Locations, Slovakia
RHEACELL Clinical Trial Site
Multiple Locations, Sweden
RHEACELL Clinical Trial Site
Multiple Locations, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.